Labcorp v. Qiagen (Fed. Cir., August 13, 2025) 2023-2350
This opinion concerns an appeal from the United States Court of Appeals for the Federal Circuit concerning a patent infringement case. The plaintiffs-appellees, including Laboratory Corporation of America Holdings, successfully sued defendants-appellants Qiagen Sciences, LLC, for infringing their U.S. Patent 10,017,810 and U.S. Patent 10,450,597, which relate to methods for preparing DNA samples. The jury initially awarded damages to the plaintiffs; however, the Court of Appeals reversed the lower court's decision, finding insufficient evidence to support the infringement claims for both…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.